Health Information Technology Usability Evaluation Scale (Health-ITUES) and User-Experience Questionnaire (UEQ) for 3D Intraoperative Cognitive Navigation (ICON3D) System for Urological Procedures.

Journal: Medicina (Kaunas, Lithuania)
Published Date:

Abstract

In recent years, the adoption of 3D models for surgical planning and intraoperative guidance has gained a wide diffusion. The aim of this study was to evaluate the surgeons' perception and usability of ICON3D platform for robotic and laparoscopic urological surgical procedures. During the 10th edition of the Techno-Urology Meeting, surgeons and attendees had the opportunity to test the new ICON3D platform. The capability of the user to manipulate the model with hands/mouse, the software usability, the quality of the 3D model's reproduction, and the quality of its use during the surgery were evaluated with the Health Information Technology Usability Evaluation Scale (Health-ITUES) and the User-Experience Questionnaire (UEQ). Fifty-three participants responded to the questionnaires. Based on the answers to the Health-ITUES questionnaire, ICON3D resulted to have a positive additional value in presurgical/surgical planning with 43.4% and 39.6% of responders that rated 4 (agree) and 5 (strongly agree), respectively. Regarding the UEQ questionnaire, both mouse and infrared hand-tracking system resulted to be easy to use for 99% of the responders, while the software resulted to be easy to use for 93.4% of the responders. In conclusion, ICON3D has been widely appreciated by urologists thanks to its various applications, from preoperative planning to its support for intraoperative decision-making in both robot-assisted and laparoscopic settings.

Authors

  • Enrico Checcucci
    Division of Urology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
  • Federico Piramide
    Department of Urology, "San Luigi Gonzaga" Hospital, University of Turin, Orbassano (Turin), Italy.
  • Sabrina De Cillis
    Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy.
  • Gabriele Volpi
    Department of Urology, "San Luigi Gonzaga" Hospital, University of Turin, Orbassano (Turin), Italy.
  • Alberto Piana
    Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy.
  • Paolo Verri
    Department of Oncology, Division of Urology, University of Turin, San Luigi Gonzaga Hospital, Orbassano (Turin), Italy.
  • Andrea Bellin
    Division of Urology, Department of Oncology, School of Medicine, San Luigi Hospital, University of Turin, 10043 Orbassano, Italy.
  • Michele Di Dio
    Division of Urology, Department of Surgery, SS Annunziata Hospital, Cosenza, Italy.
  • Cristian Fiori
    Division of Urology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
  • Francesco Porpiglia
    Division of Urology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
  • Daniele Amparore
    Division of Urology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
  • Icon Study Group